ImaRx Drops After Market Debut

Tucson, Arizona-based ImaRx Therapeutics, which develops drug delivery technology, debuted on the Nasdaq Thursday, after pricing at $5 per share, and later dropping in trading to close at $4.79 per share. The firm priced at below its initial estimated of $6.50 to $7.50 per share. The firm was looking to raise $13.95M in the offering, which was underwritten by Maxim Group and I-Bankers Securities. The firm is now listed on the NASDAQ Capital Market under the symbol "IMRX."